CD38 and systemic lupus erythematosus: Analysis of CD19+ B cells showed a higher percentage of CD38++CD24++CD10+ (TR) B cells in the TLR7hi SLE patient group, as compared to the HC and TLR7norm/lo SLE group (p = 0.0085, 1-way ANOVA) (Figures 3A,B).